Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7258 results

Sort By:

A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer

Study ID: NCT05408260
Start Date: 2022-11-18
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Ultrasonography

Automated Breast Ultrasound

Sponsor

Thomas Jefferson University

Source: clinicaltrials.gov

Share:
Add to list

Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers

Study ID: NCT04645160
Start Date: 2022-03-04
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

31

Intervention / Treatment

Pucking

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Study ID: NCT06635980
Start Date: 2025-05-14
End Date: 2034-10-21
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

Biopsy of Breast

Biospecimen Collection

Breast Surgery

Chemotherapy

Computed Tomography

Contrast Enhanced Digital Mammography

Hypofractionated Radiation Therapy

Magnetic Resonance Imaging

Positron Emission Tomography

Survey Administration

Tissue Collection

Ultrasound Imaging

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs (IGNYTE-3)

Study ID: NCT06264180
Start Date: 2024-07-11
End Date: 2034-08-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

400

Intervention / Treatment

Vusolimogenic Oderparepec

Nivolumab

Nivolumab + Relatlimab

Pembrolizumab

Single-agent chemotherapy

Sponsor

Replimune Inc.

Source: clinicaltrials.gov

Share:
Add to list

Infusion System for Hepatic Cancer

Study ID: NCT04684862
Start Date: 2021-02-08
End Date: 2029-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Medtronic SynchroMed II programmable pump connected to an Intera tapered catheter (Combined Infusion System)

Sponsor

Ronald Dematteo, M.D.

Source: clinicaltrials.gov

Share:
Add to list

Virtual Health Insurance Navigation Pilot Program for Childhood Survivors (HINTII)

Study ID: NCT05527392
Start Date: 2023-05-01
End Date: 2027-04-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

520

Intervention / Treatment

Health Insurance Navigation Tools Program

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG

Study ID: NCT03033992
Start Date: 2017-04-04
End Date: 2031-07-21
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)

Concurrent Optune and RT followed by Optune System alone

Sponsor

Pediatric Brain Tumor Consortium

Source: clinicaltrials.gov

Share:
Add to list

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

Study ID: NCT06259292
Start Date: 2023-11-13
End Date: 2033-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10000

Intervention / Treatment
Sponsor

Cure HHT

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Study ID: NCT06568692
Start Date: 2024-10-02
End Date: 2026-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

90

Intervention / Treatment

PCS6422 and capecitabine

Capecitabine

Sponsor

Processa Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Feasibility of CSF and Plasma ctDNA in BRAF-altered Glioma During Treatment With Plixorafenib

Study ID: NCT06610682
Start Date: 2025-04-07
End Date: 2026-05-15
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

15

Intervention / Treatment

Pixorafenib

Cobicistat 150 MG [Tybost]

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list